Lanreotid Amdipharm for Neuroendocrine tumors
Quick answer: Lanreotid Amdipharm is used for Neuroendocrine tumors as part of a somatostatin analog treatment regimen. Long-acting somatostatin analog that binds somatostatin receptors (mainly SSTR2 and SSTR5) to inhibit growth hormone and gut hormone secretion The specific dosing for Neuroendocrine tumors is determined by your prescriber based on individual factors.
Why is Lanreotid Amdipharm used for Neuroendocrine tumors?
Lanreotid Amdipharm belongs to the Somatostatin analog class. Long-acting somatostatin analog that binds somatostatin receptors (mainly SSTR2 and SSTR5) to inhibit growth hormone and gut hormone secretion This action makes it useful for treating or managing Neuroendocrine tumors in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Lanreotid Amdipharm is the right choice for a specific patient depends on the type and severity of Neuroendocrine tumors, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Neuroendocrine tumors
Common adult dosing range: 60-120 mg deep SC every 4 weeks. The actual dose for Neuroendocrine tumors depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Lanreotid Amdipharm medicine page.
What to expect
Lanreotid Amdipharm treatment for Neuroendocrine tumors typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Neuroendocrine tumors
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Lanreotid Amdipharm is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Somatostatin analog for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Lanreotid Amdipharm
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Lanreotid Amdipharm full prescribing information · All Somatostatin analog alternatives
Frequently asked questions
How effective is Lanreotid Amdipharm for Neuroendocrine tumors?
Effectiveness varies by individual response, dose, and severity. Lanreotid Amdipharm is one of several treatment options for Neuroendocrine tumors, supported by clinical evidence within the somatostatin analog class. Discuss expected response with your prescriber.
How long do I need to take Lanreotid Amdipharm for Neuroendocrine tumors?
Treatment duration depends on the nature of Neuroendocrine tumors — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Lanreotid Amdipharm when used for Neuroendocrine tumors?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Lanreotid Amdipharm for Neuroendocrine tumors?
Yes. Multiple medicines and non-drug options exist for Neuroendocrine tumors. Alternatives within the somatostatin analog class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.